Cytosorbents Corporation
CTSO
$0.8911
-$0.022-2.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.20M | 11.59M | 3.28M | 5.69M | 8.46M |
| Total Receivables | 7.74M | 7.67M | 7.32M | 6.63M | 7.82M |
| Inventory | 3.71M | 3.02M | 2.73M | 3.25M | 4.32M |
| Prepaid Expenses | 1.33M | 3.14M | 3.27M | 1.03M | 1.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 5.00M | -- | -- |
| Total Current Assets | 22.99M | 25.41M | 21.60M | 16.60M | 21.96M |
|
|
|||||
| Total Current Assets | 22.99M | 25.41M | 21.60M | 16.60M | 21.96M |
| Net Property, Plant & Equipment | 19.69M | 20.09M | 20.51M | 20.92M | 21.21M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.74M | 3.70M | 3.75M | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.58M | 1.57M | 1.51M | 10.29M | 10.26M |
| Total Assets | 47.99M | 50.78M | 47.37M | 47.80M | 53.43M |
|
|
|||||
| Total Accounts Payable | 3.39M | 3.33M | 3.34M | 2.34M | 3.05M |
| Total Accrued Expenses | 4.61M | 4.45M | 4.75M | 4.82M | 5.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 495.00K | 473.90K | 452.70K | 432.00K | 412.10K |
| Total Finance Division Other Current Liabilities | 1.35M | 1.49M | 1.28M | 837.60K | 1.30M |
| Total Other Current Liabilities | 1.35M | 1.49M | 1.28M | 837.60K | 1.30M |
| Total Current Liabilities | 9.84M | 9.74M | 9.82M | 8.43M | 10.34M |
|
|
|||||
| Total Current Liabilities | 9.84M | 9.74M | 9.82M | 8.43M | 10.34M |
| Long-Term Debt | 14.38M | 14.19M | 14.00M | 13.81M | 13.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.19M | 12.32M | 12.44M | 12.57M | 12.68M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 36.40M | 36.24M | 36.26M | 34.80M | 36.69M |
|
|
|||||
| Common Stock & APIC | 319.09M | 318.51M | 310.86M | 308.50M | 307.57M |
| Retained Earnings | -303.54M | -305.49M | -304.01M | -295.34M | -293.01M |
| Treasury Stock & Other | -3.96M | 1.52M | 4.25M | -156.90K | 2.17M |
| Total Common Equity | 11.59M | 14.54M | 11.11M | 13.00M | 16.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.59M | 14.54M | 11.11M | 13.00M | 16.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.59M | 14.54M | 11.11M | 13.00M | 16.74M |
|
|
|||||